A Possible Potentiating Antidepressant Effect of Venlafaxine by Recombinant Rat Leptin in a Rat Model of Chronic Mild Stress
DOI:
https://doi.org/10.6000/1927-3037.2013.02.01.3Keywords:
Chronic mild stress [CMS], prefrontal cortex, leptin, venlafaxine, forced swimming test, albino ratsAbstract
The present study was designed to investigate the possible changes in forced swimming test (FST), prefrontal cortical glutamate and gamma amino-butyric acid (GABA) contents by leptin and/or venlafaxine in chronic mild stress (CMS)-induced anhedonia in male albino rats. They were divided into 5 groups: the first group was not exposed to CMS, the second group received normal saline with exposure to CMS, the third group received leptin 1 mg/kg/day intraperitoneally (ip) for 3 weeks after CMS induced anhedonia was assesed by sucrose consumption test, the fourth group received venlafaxine 8 mg/kg/day ip for 3 weeks after CMS protocol, and the fifth group was received both medications for 3 weeks. Leptin and/or venlafaxine restored the changes in sucrose consumption test, behavioural assessment by forced swimming test (FST) as well as prefrontal cortical GABA and glutamate contents in the control stressed group. Furthermore, combination of both treatments seems to be more efficacious than venlafaxine alone in these parameters. In conclusion,these results showed a potential antidepressant role of leptin and beneficial therapeutic interaction with venlafaxine by affecting the GABA and glutamate level in prefrontal cortex. These actions could make leptin a potentially valuable drug for the treatment of depression.
References
Du L, Faludi G, Palkovits M, Sotonyi P, Bakish D, Hrdina PD. High activity-related allele of MAO-A gene associated with depressed suicide in males. Neuroreport 2002; 13(9): 1195-98. http://dx.doi.org/10.1097/00001756-200207020-00025
Scott LV, Dinan TG. Vasopressin as a target for antidepressant development: an assessment of the available evidence. J Affect Disord 2002; 72(2): 113-24. http://dx.doi.org/10.1016/S0165-0327(02)00026-5
Krystal JH, Sanacora G, Blumberg H, Anand A, Charney DS, Marek G, et al. Glutamate and GABA systems as targets for novel antidepressant and mood-stabilizing treatments. Mol Psych 2002; 7: S71-S80. DOI: 10.1038/sj/mp/4001021
Frazer A. Pharmacology of antidepressants. J Clin Psychopharmacol 1997; 17(Suppl 1): 2S-18S.
Elmquist JK, Bjorbaek C, Ahima RS, Flier JS, Saper CB. Distributions of leptin receptor mRNA isoforms in the rat brain. J Comp Neurol 1998; 395: 535-47. http://dx.doi.org/10.1002/(SICI)1096-9861(19980615)395:4<535::AID-CNE9>3.0.CO;2-2
Lu XY, Kim CS, Frazer A, Zhang W. Leptin: a potential novel antidepressant. Proc Natl Acad Sci USA 2006; 103: 1593-98. http://dx.doi.org/10.1073/pnas.0508901103
Fulton S, Pissios P, Manchon RP, Stiles L, Frank L, Pothos EN, et al. Leptin regulation of the mesoaccumbens dopamine pathway. Neuron 2006; 51: 811-22. http://dx.doi.org/10.1016/j.neuron.2006.09.006
Ahima RS, Osei SY. Leptin signaling. Physiol Behav 2004; 81: 223-41. http://dx.doi.org/10.1016/j.physbeh.2004.02.014
Delgado PL. Depression: the case for a monoamine deficiency. J Clin Psych 2000; 61(Suppl 6): 7-11.
Brambilla P, Perez J, Barale F, Schettini G, Soares JC. GABAergic dysfunction in mood disorders. Mol Psych 2003; 8(8): 721-37. doi:10.1038/sj.mp.4001395 http://dx.doi.org/10.1038/sj.mp.4001362
Goodwin FK. Jamison KR. Manic-depressive illness. New York, NY 1990; Oxford University Press.
Petty F, Kramer GL, Fulton M, Moeller FG, Rush AJ. Low plasma GABA is a trait-like marker for bipolar illness. Neuropsychopharmacol 1993; 9(2): 125-32.
Sanacora G, Mason GF, Rothman DL, Krystal JH. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psych 2002; 159(4): 663-65. http://dx.doi.org/10.1176/appi.ajp.159.4.663
David D, Bourin M, Jego G, Przybylski C, Jolliet P, Gardier A. Effects of acute treatment with paroxetine, citalopram and venlafaxine in vivo on noradrenaline and serotonin outflow: a microdialysis study in Swiss mice. Br J Pharmacol 2003; 140: 1128-36. http://dx.doi.org/10.1038/sj.bjp.0705538
Willner P, Towell A, Sampson D, Sophokleous S, Muscat R. Reduction of sucrose preference by chronic unpredictable mild stress and its restoration by a tricyclic antidepressant. Psychopharmacol (Berl) 1987; 93: 358-64. http://dx.doi.org/10.1007/BF00187257
Solberg LC, Horton TH, Tarek FW. Circadian rhythms and depression: effects of exercise in an animal model. Am J Physiol Regul Integr Comp Physiol 1999; 276: R152-R161.
Detke M, Johnson J, Lucki I. Acute and chronic antidepressant drug treatment in the rat forced swimming test model of depression. Exp Clin Psychopharmacol 1997; 5: 107-12. http://dx.doi.org/10.1037/1064-1297.5.2.107
Bradford M. A Rapid and Sensitive Method for the Quantitation of Microgram Quantities of Protein Utilizing the Principle of Protein-Dye Binding. Anal Biochem 1976; 72: 248-54. http://dx.doi.org/10.1016/0003-2697(76)90527-3
Gunawan S, Walton N, Treiman D. High performance liquid chromatography determination of selected amino acids in rat brain by precolumn derivatization with phenylisothiocyanate. J Chrom 1990; 503(1): 177-87.
Larsson H, Ahren B. Short-term dexamethasone treatment increases plasma leptin independently of changes in insulin sensitivity in healthy women. J Clin Endocrinol Metab 1996; 81: 4428-32. http://dx.doi.org/10.1210/jc.81.12.4428
Miell JP, Englaro P, Blum WF. Dexamethasone induces an acute and sustained rise in circulating leptin levels in normal human subjects. Horm Metab Res 1996; 28: 704-7. http://dx.doi.org/10.1055/s-2007-979882
Deuschle M, Blum WF, Englaro P, Schweiger U, Weber B, Pflaum CD, et al. Plasma leptin in depressed patients and healthy controls. Horm Metab Res 1996; 28: 714-17. http://dx.doi.org/10.1055/s-2007-979885
Jow GM, Yang TT, Chen CL. Leptin and cholesterol levels are low in major depressive disorder, but high in schizophrenia. J Affect Disord 2006; 90: 21-27. http://dx.doi.org/10.1016/j.jad.2005.09.015
Kraus T, Haack M, Schuld A, Hinze-Selch D, Pollmacher T. Low leptin levels but normal body mass indices in patients with depression or schizophrenia. Neuroendocrinol 2001; 73: 243-47. http://dx.doi.org/10.1159/000054641
Streeter CC, Hennen J, Ke Y, Jensen JE, Sarid-Segal O, Nassar LE, et al. Prefrontal GABA levels in cocaine-dependent subjects increase with pramipexole and venlafaxine treatment. Psychopharmacol (Berl) 2005; 2: 1-11 http://dx.doi.org/10.1007/s00213-005-0121-5.
Francis J, Mohan Kumar S, Mohan Kumar P. Leptin inhibits norepinephrine efflux from the hypothalamus in vitro: role of gamma aminobutyric acid. Brain Res 2004; 10: 10-16.
Zang R, Li D, Tang I, Wang J, Yang S. Cell-based assays in high-throughput screening for drug discovery. IJBWI 2012; 1: 31-51. http://dx.doi.org/10.6000/1927/3037.2012.01.01.02
Downloads
Published
How to Cite
Issue
Section
License
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .
